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Heronamide C is a 20-membered polyene macrolactam isolated 
from a marine-derived Streptomyces sp. and shows potent antifungal 
activity by targeting membrane phospholipids. Testing the stability 
of heronamide C under UV irradiation (365 nm) revealed that her-
onamide C is converted mainly to heronamide B and a minor prod-
uct, heronamide A, as determined by LC-MS analysis. In addition, the 
antifungal activity of heronamides A and B as tested against fission 
yeast was much weaker than that of heronamide C. Taking these re-
sults together, further structure-activity relationship studies of the her-
onamides are helpful for developing a chemical probe and a promising 
lead compound for antifungal drugs.
Keywords: Heronamides, Polyene, Macrolactam, a Marine-derived 
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抗真菌作用を持つヘロナミド C の紫外線照射（365 nm）によ
る安定性試験を行った。また、ヘロナミド C と紫外線照射によっ
て生成したヘロナミド A、B の抗真菌作用を調べた。その結果、
ヘロナミド C は紫外線照射によってヘロナミド A、B（主変換
体）へと変換され、それらはヘロナミド C ほどの抗真菌活性
を示さないことが明らかになった。これらの結果から、ヘロナ









Natural products derived from medicinal plants, microbial me-
tabolites, marine organisms, and other biological sources hold much 
promise for developing new medicine (1). For example, penicillin 
and amphotericin B antibiotics were produced by Penicillium sp. and 
Streptomyces sp., respectively. However, as severe problems such as 
drug-resistance have existed for some time, it is necessary to discover 
or synthesize new molecules or pharmacophores to overcome them.
Heronamide C is a 20-membered polyketide macrolactam isolated 
Fig. 1. Chemical structures of heronamides A, B, and C.
The chemical structures of heronamides A, B, and C were originally re-
ported in 2010 by Raju, R. et al. (2), and were recently revised by our ex-
tensive NMR analysis and synthetic methodology, as shown in Fig. 1 (3–5).
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from a marine-derived Streptomyces sp (2,3). This macrolactam shows 
potent antifungal activity by targeting membrane phospholipids (3). 
The antifungal activity of heronamide C is as potent as that of ampho-
tericin B, a well-known polyene macrolide that is used clinically. The 
chemical structures of heronamides A, B, and C were unambiguously 
revised very recently by our extensive NMR analysis and synthetic 
methodology, as shown in Fig. 1 (3–5).
Herein we investigated not only the stability of heronamide C under 
UV irradiation (365 nm) but also the biological activities of the result-
ing converted products, heronamides A and B.
Materials & Methods
Heronamide C Conversion to Heronamides A and B
First, heronamides A, B, and C (1.0 µg) served as standard sam-
ples (3,4) for LC-MS analysis (ESI-IT-TOF; Shimadzu, Japan). Next, 
a solution of heronamide C (2.0 mM) in DMF was irradiated with UV 
(365 nm) for 6 min before, aliquots (1 µL) were removed for LC-MS 
analysis.
The LC conditions were as follows: Cosmosil 5C8-MS (Nacalai 
Tesque, Japan), ϕ3 × 150 mm, 5 μm; 0.2 mL/min; gradient elution 
from 60 to 100% aqueous MeOH over 10 min and 100% MeOH for 10 
min). The three ion peaks (1, 2, and 3) observed on the chromatogram 
shown in Fig. 2 corresponded to heronamides C, A, and B, respective-
ly. All MS spectra were taken in positive ion mode by ESI-IT-TOF.
Biological Activities of Heronamides A, B, and C against Fission 
Yeast Cells
Growth inhibition by heronamides was tested as previously de-
scribed (6). Heronamides A, B, and C were added to fission yeast 
cells growing in liquid culture (3.3 × 10-3 OD595, Schizosaccharomyces 
pombe, JY1 (h -)) and incubated at 30 ºC for 24 h. Changes in turbidity 
were determined by measuring the absorbance at 595 nm with a micro-
plate reader (EnVision, Thermo Fisher Scientific, USA). The cell via-
bility was calculated relative to that of DMSO-treated (control) cells.
Results & Discussion
Heronamide C Conversion to Heronamides A and B
We investigated the stability of heronamide C under UV irradiation 
(365 nm). Peak 1, corresponding to heronamide C in the LC-MS anal-
ysis, showed a retention time of 15.6 min before irradiation with an 
ion peak (m/z) of 450 (Figs. 2a & 3a). After UV irradiation for 6 min, 
peak 1 almost disappeared, whereas two new peaks appeared at 14.8 
min and 16.8 min (Fig. 2b). The ion peak of the major product (peak 
3) was 432, which is identical to that of heronamide B; heronamide B 
showed a dehydration peak in this condition (Fig. 3c). In addition, the 
minor product (peak 2) was determined to correspond to heronamide 
A (Fig. 3b). These results indicate that heronamide C was converted 
mainly to heronamide B with a minor product heronamide A under UV 
irradiation at 365 nm. 
Biological Activities of Heronamides A, B, and C against Fission 
Yeast Cells
We investigated the biological activities of heronamides A, B, and 
C against fission yeast cells. The minimum inhibitory concentration 
(MIC) value calculated for heronamide C in this assay was 0.13 μM, 
whereas those for heronamides A and B were over 20 and 50 μM, re-
spectively (Fig. 4). In contrast, the MIC value of amphotericin B was 
0.27 μM (data not shown). These results suggest that the 20-membered 
polyene macrolactam ring in heronamide C plays a crucial role in its 
antifungal activity.
a) Before UV irradiation
















Fig. 2.  Conversion of heronamide C to heronamides A and B under UV irra-
diation at 365 nm.
The LC profiles obtained by LC-MS analysis were recorded at 220 nm 
(pink), 231 nm (blue), and 290 nm (brown). Peak 1 shows heronamide C, 
while peaks 2 and 3 show heronamides A and B, respectively.
a)  MS analysis of peak 1
b)  MS analysis of peak 2
c)  MS analysis of peak 3


































Fig. 3. MS profile of peaks 1, 2, and 3 obtained by LC-MS.
The ion peaks (m/z) observed for peaks 1 and 2 were established as 450 
(M+H)+ and 466 (M+H)+, which are identical to those of heronamides C and 
A, respectively. The ion peak (m/z) of peak 3 was 432 (M-H2O+H)+, which 
matches that of heronamide B.
65
薬科学
In summary, we determined that heronamide C, the metabolite 
from a marine-derived Streptomyces sp., was mostly converted to her-
onamide B under UV irradiation (365 nm). In addition, we found that 
the antifungal activity of heronamides A and B was much weaker than 
that of heronamide C. Furthermore structure-activity relationship stud-
ies of heronamides will be helpful for developing a chemical probe as 
well as a promising lead compound for antifungal drugs.
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Fig. 4.  Biological activities of heronamides A, B, and C against fission yeast 
cells.
Fission yeast cells were incubated in either the presence or absence of 
heronamides A, B, and C at 30 ºC for 24h. Cell viability was determined by 
measuring the turbidity. The MIC values of heronamides A, B, and C were 
>20, 50, and 0.13 μM, respectively. Data represent the mean values of three 
independent experiments. Error bars indicate the SD.
